crsp-ex991_7.htm
CRISPR to fix bad blood: a new tool in basic and clinical hematology | Haematologica
CRISPR Therapeutics and ViaCyte, Inc. Announce First
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy - ScienceDirect
CRISPR-Cas9 Clinical Trials as of February 2018. | Download Table
CRISPR Clinical Trials to Watch for in 2022 and Beyond
CRISPR-based therapeutics: The race is on - Pharmaceutical Technology
Current clinical trials in hematology using the CRISPR/Cas9 system. | Download Scientific Diagram
CRISPR Therapeutics on Twitter: "Today, @CRISPRTX and @ViaCyte announced that the first patient has been dosed in the Phase 1 clinical trial of VCTX210 for the treatment of type 1 diabetes (T1D).
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
Gene-editing pipeline takes off
Frontiers | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
CRISPR Therapeutics Plans First CRISPR Clinical Trial in Europe for 2018
CRISPR Therapeutics Plans First CRISPR Clinical Trial in Europe for 2018
CRISPR enters its first human clinical trials | Science News
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)
CRISPR Therapeutics and Vertex Announce New Clinical Data
How CRISPR Is Changing Cancer Research and Treatment - NCI
News: Latest Gene Editing Clinical Trial - CRISPR Medicine
News: CRISPR clinical trials overview 2020 - CRISPR Medicine
CRISPR clinical trials for inherited diseases listed in this review. | Download Scientific Diagram
Crispr Therapeutics Plans to Launch Its First Clinical Trial in 2018 | WIRED
News: CRISPR Therapy Turns a Corner With First Cures In Sight - CRISPR Medicine
